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2:00 PM-5:30 PM 
2:00 PM-3:30 PM 
4:00 PM-5:30 PM 
6:00 PM-7:30 PM 
7:30 PM-9:00 PM 
Joint Session: OARSI and NIH/NIAMS 
Biomarkers in the Osteoarthritis Initiative and in Clinical Trials 
The NIH OA Initiative: Overview and Update 
Biomarkers and Biomarker - Validation in Osteoarthritis 
Michael Nevitt, MD, MPH 
The OAI: Where Do We Go From Here? 
Gay/e E. Lester, PhD 
Pilot Study Analyses: Results and Perspectives 
Erika Schneider, PhD 
OA Biomarkers: The Clinical Trial Perspective 
Radiography 
Marie-Pierre He//io-/e Graverand, MD, PhD, DSc 
Magnetic Resonance Imaging 
Jeff Eve/hoch, PhD 
Biochemical Markers 
Joanne Jordan, MD, MPH 
Award Presentations 
Session Chairs: Martin Lotz, Linda Sandell 
Lifetime Achievement Awardees 
David S. Howell, MD 
Leon Sokoloff, MD 
Clinical Research Award 
Kenneth D. Brandt, MD 
Basic Science Award 
Sergio A. Jimenez, MD 
Opening Reception with Exhibits 
Friday, December  9 
7:15 AM-8:15 AM 
8:15 AM-  10:00 AM 
Breakfast Session A 
Grading System for Mouse Osteoarthritis 
Qian Chen, PhD 
Sonya S. Glasson, PhD 
Breakfast Session B 
Design and Conduct of Clinical Trials in OsteoarthriUs 
Marc C. Hochberg, MD, MPH 
Plenary Session I 
Presentation of highest-rated abstracts 
Session Chairs: Francis Berenbaum, Mary B. Goldring 
vii 
viii Sc ient i f ic  P rogram 
8:15 AM-8 :30  AM 
8:30 AM -8 :45  AM 
8:45 AM -9 :00  AM 
9:15 AM-9 :30  AM 
9:30 AM -9 :45  AM 
9:45 AM-  10:00 AM 
10:30 AM -12:00 PM 
10:30 AM - 11:00 AM 
11:00AM-11:15  AM 
11:15 AM-11:30AM 
11:30 AM-11:45  AM 
A1 CALCITONIN DIRECTLY ATTENUATES COLLAGEN TYPE II DEGRADATION BY INHIBITION OF 
MMP EXPRESSION AND ACTIVITY IN ARTICULAR CHONDROCYTES 
BC Sondergaard 1 , K Henriksen 2, H Wulf 2, S Ostergaard 1 , P Qvist 1 , YZ Bagger  1 , C Christ iansen 1 , LB 
Tank61 , MA Karsdal 2 
1Pharmacology and Biomarkers, Nordic Bioscience & Center for Clinical and Basic Research, Herlev, 
Denmark; 2 pharmos Bioscience, Herlev, Denmark 
Young Investigator Awardee 
A2 GADD4513 IS NOVEL MEDIATOR OF MMP-13 GENE EXPRESSION DURING CHONDROCYTE 
HYPERTROPHY 
K Ijiri 1 , LF Zerbini 1 , H Peng 1 , N Walsh 1 , XL Huang 1 , H Otu 1 , B Lu 2, TA Libermann 1 , MB Goldr inq 1 
1 New England Baptist Bone & Joint Institute, Beth Israel Deaconess Medical Center, Boston, MA; 
2Department of Immunology, University of Pittsburgh, Pittsburgh, PA 
A3 THE CATABOLIC PATHWAY MEDIATED BY TOLL-LIKE RECEPTORS IN CHONDROCYTES 
HA Kim 1 , HY Choi 1 , CS Yoon 1 , ML Cho 2, JY Jhun 2, HJ Oh 2, HY Kim 2 
1 Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Kyunggi, Korea; 2 Rheumatism 
Research Center, Catholic University, Seoul, Korea 
A4 EFFECTS OF GLUCOSAMINE SULFATE ON 6-MONTH CONTROL OF KNEE OSTEOARTHRITIS 
SYMPTOMS VS PLACEBO AND ACETAMINOPHEN: RESULTS FROM THE GLUCOSAMINE 
UNUM IN DIE EFFICACY (GUIDE) TRIAL 
G Herrero-Beaumont  1 , JA Rom~.n 2, MC Trabado 3, FJ Blanco 4, P Benito 5, E Mart in-Mola 6, J Paulino 7, 
JL Marenco 8, A Porto 9, A Laffon 1°, D Ara~jo 11 , M Figueroa 12, J Branco 13 
1Rheumatology, Fund J Diaz, Madrid, Spain; 2H Peset, Valencia; 3H Clinic, Barcelona; 4CH Juan 
Canalejo, A Coruha; 5H del Mar, Barcelona; 6H U La Paz, Madrid; 7C H C R, Ciudad Real; 8H N.S. de 
Valme, Sevilla; 9H U, Coimbra; l°H Princesa, Madrid; 11H C. Bertandos, Ponte de Lima; 12H Donostia, 
San Sebastian; 13H E. Moniz, Lisboa, Portugal 
A5 RISEDRONATE PROTECTS AGAINST SUBCHONDRAL BONE LOSS IN OA KNEE PATIENTS 
WITH PROGRESSIVE JOINT SPACE NARROWING 
JC Buckland-Wright 1, EA Messent  1 , GA Cline 2, JF Beary 2, JM Meyer 2 
1Appfied Clinical Anatomy, King's College London, London, United Kingdom; 2procter & Gamble 
Pharmaceuticals, Mason, OH 
A6 BIOCHEMICAL MARKERS OF TYPE II COLLAGEN SYNTHESIS AND DEGRADATION PREDICT 
LONG TERM DISEASE PROGRESSION IN EARLY KNEE OSTEOARTHRITIS: A 5 YEAR 
LONGITUDINAL STUDY 
P Garnero, M Sharif, N Charni, R Granell, L Sandell, C Whittles, J Kirwan 
Molecular Markers, Synarc, Lyon, France; Department of Anatomy, University of Bristol, Bristol, United 
Kingdom; Molecular Markers, Synarc, Lyon, France; Department of Rheumatology, University of 
Bristol, Bristol, United Kingdom; Department of Orthopaedic Surgery, Washington University School of 
Medicine, St. Louis, MO; Department of Anatomy, University of Bristol, Bristol, United Kingdom; 
Department of Anatomy, University of Bristol, Bristol, United Kingdom 
Concurrent Sessions 
Biomarkers 
Session Chairs: Virginia Byers Kraus, Pierre D. Delmas 
Clinical Use of Biological Markers 
Pierre Delmas, MD, PhD 
A7 TOTAL QUANTITATIVE OSTEOARTHRITIS LOAD(TQOL) ASSESSMENT TOOL: A PROPOSED 
METHODOLOGY FOR BIOMARKER CORRELATIONS 
RW Moskowitz, MM Hooper, D Holderbaum 
Medicine, University Hospitals of Cleveland, Cleveland, OH 
A8 DIURNAL VARIATION OF BIOMARKERS IN PATIENTS WITH RADIOGRAPHIC KNEE 
OSTEOARTHRITIS 
SY Kong 1 , TV Stabler 1 , LG Criscione 1 , AL Elliott 2, JM Jordan 2, VB Kraus 1 
1 Department of Medicine, Duke University Medical Center, Durham, NC; 2Department of Medicine, 
University of North Carolina at Chapel Hill, Chapel Hill, NC 
A9 EROSIVE OSTEOARTHRITIS: CLINICAL AND SEROLOGICAL CHARACTERIZATION OF A 
DISTINCT SUBTYPE OF OSTEOARTHRITIS 
TPS Rao 1'3, AL Metzger  4, JR Sama 4, Vl Petkov 1,3, RA Adler ~,3, D Disler 3,5, P Carlson 1 , AG Stern ~,2 
1Rheumatology, McGuire Veterans Affairs Medical Center; 2Arthritis and Osteoporosis Center of 
3 4 Richmond; Virginia Commonwealth University School of Medicine; Rheumatology Diagnostics 
Laboratory, Inc, CA; 5Commonwealth Radiology, Richmond, VA 
Osteoar thr i t i s  and Cart i lage Vo1.13, Supp lement  A ix 
11:45 AM-12:00  PM A10 COLL 2-1 AND COLL 2-1 NO2 IN OA PATIENTS BEFORE AND AFTER HIP OR KNEE 
REPLACEMENT 
M Deberg 1 , A Labasse 1 , E Quettier 2, JE Dubuc 2, Y Henrotin 1 
1Bone and Cartilage Research Unit, University of Liege, CHU, Liege, Belgium; 2Hospital Princess 
Paola, Marche-en-Famenne, Belgium 
10:30 AM-11:00  AM OA and Development 
Session Chairs: Linda Sandell, Martin Lotz 
Role of Matrix Metal loproteinases in Cart i lage and Bone During Skeletal Remodel ing 
Stephen M. Krane, MD 
11:00AM-11:15  AM Al l  DEGRADATION OF SMALL LEUCINE-RICH PROTEOGLYCANS BY MMP-13: IDENTIFICATION OF 
A NEW BIGLYCAN CLEAVAGE SITE 
J Monfort  Faure 1 , G Tardif 1 , P Reboul 1 , F Mineau 1 , P Roughley 2, JP Pelletier 1 , J MarteI-Pelletier 1
10steoarthritis Research Unit, University of Montreal Hospital Centre, Notre-Dame Hospital, Montreal, 
QC, Canada; 2Genetics Unit, Shriner's Hospital for Children, Montreal, QC, Canada 
Young Investigator Awardee 
11:15 AM-11:30AM A12 A DISTINCT CHONDROCYTE SUBSET EXPRESSING TRANSGLUTAMINASE FXIIIA PROMOTES 
HYPERTROPHIC DIFFERENTIATION MOLECULARLY MEDIATED BY FXIIIA ALA457, THE 
CALCIUM BINDING DOMAIN (T458-E495) AND NETWORKING WITH TRANSGLUTAMINASE 2 
KA Johnson, RA Terkeltaub 
Division of Rheumatology/Allergy/Immunology, VAMC/UCSD, La Jolla, CA 
11:30 AM-11:45  AM A13 INCREASED WISP1 EXPRESSION IN SYNOVIUM AND CARTILAGE DURING EXPERIMENTAL 
AND HUMAN OSTEOARTHRITIS 
AB Blom 1 , SM Brockbank 2, PL van Lent 1 , PM van der Kraan 1 , P Newham 2, WB van den Berg 1 
1 Experimental Rheumatology and Advanced Therapeutics, Radboud University Nijmegen Medical 
Center, Nijmegen, Netherlands; 2AstraZeneca, Respiratory and Inflammation Research Area, Alderley 
Park, Macclesfield, Cheshire, United Kingdom 
11:45 AM-12:00  PM A14 CHONDROCYTE CELL DEATH MEDIATED BY REACTIVE OXYGEN SPECIES-DEPENDENT 
ACTIVATION OF PKC-BETAI 
RF Loeser 1 , M DelCarlo 2 
1Molecular Medicine, Wake Forest University Health Sciences, Winston-Salem, NC; 2Biochemistry, 
Rush College of Medicine, Chicago, IL 
1:30 PM-3 :00  PM Poster Session h Presenters in Attendance 
Posters P50-P207 
3:00 PM-4 :30  PM Concurrent Sessions 
Understanding Pain in Osteoarthritis 
Session Chairs: Leslie J. Crofford, Bernard Combe 
3:00 PM-3 :30  PM Molecular  Events of Chronic Pain 
James L. Henry, PhD 
3:30 PM-3 :45  PM A15 PLANNING CLINICAL TRIALS IN OA: RELATIONSHIP BETWEEN CHOICE OF OUTCOME 
MEASURE, LEVEL OF SYMPTOMS AND SAMPLE SIZE NEEDED TO DISTINGUISH TREATMENT 
EFFECTS FROM PLACEBO EFFECTS 
DJ Reda 1 , DO Clegg 2, H Shi 1 , the GAIT Investigators 
1 Cooperative Studies Program, Department of Veterans Affairs, Hines, IL; 2Department of Internal 
Medicine, University of Utah School of Medicine, Salt Lake City, UT 
3:45 PM-4 :00  PM A16 UPREGULATION OF PROTEINASE-ACTIVATED RECEPTOR (PAR)-2 IN HUMAN 
OSTEOARTHRITIC TISSUES: A NEW PATHWAY FOR THE MEDIATION OF JOINT DESTRUCTION 
JP Pelletier, C Boileau, F Mineau, C Geng, M Boily, J MarteI-Pelletier 
Osteoarthritis Research Unit, University of Montreal Hospital Centre, Notre-Dame Hospital, Montreal, 
QC, Canada 
4:00 PM-4 :15  PM A17 FIVE-YEAR KNEE PAIN PATTERNS IN RELATION TO BASELINE KNEE MRI FINDINGS: 
THE HEALTH ABC STUDY 
H Chen 1 , M Nevitt 2, C Peterfy 6, E Simonsick 1 , G Lester 3, A Newman 4, K Kwoh 4, L Carbone 5, S 
Satterfield 5, S Ling 1 , T Harris 1 
I lRR National Institute on Aging, MD; 2Epi Biostat, University of Cafifornia, San Francisco, CA; 3MDB, 
National Institute of Arthritis and Musculoskeletal nd Skin Diseases, MD; 4Medicine, University of 
Pittsburgh, PA; 5Medicine, University of Tennessee, 6 TN; Musculolskeletal, Synarc, Inc, CA 
Young Investigator Awardee 
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4:15 PM-4 :30  PM 
3:00 PM-3 :30  PM 
3:30 PM-3 :45  PM 
3:45 PM-4 :00  PM 
4:00 PM-4 :15  PM 
4:15 PM-4 :30  PM 
5:00 PM-6 :30  PM 
5:00 PM-5 :30  PM 
5:30 PM-5 :45  PM 
5:45 PM-6 :00  PM 
6:00 PM-6 :15  PM 
A18 KNEE PAIN OVER 6-9 YEARS IN A MENISCECTOMY POPULATION WITH AND WITHOUT 
RADIOGRAPHIC KNEE OSTEOARTHRITIS 
M Englund, EM Roos, LL Dahl, LS Lohmander 
Department of Orthopedics, Lund University, Lund, Sweden 
Mechanosignaling in Chondrocytes 
Session Chairs: Thomas Aigner, Farshid Guilak 
Integrin Regulation 
Martin Humphries, PhD 
A19 Ras/Raf/MEK/ERK PATHWAY IS REQUIRED FOR INCREASED EXPRESSION OF MMP-13 IN 
HUMAN CHONDROCYTES BY TYPE II COLLAGEN-DEPENDENT ACTIVATION OF DDR2 
H Peng 1 , K Hu 2, L XU 2, BR Olsen 2'3, MB Goldring 1 , Y Li 2 
1Rheumatology, Beth Israel Deaconess Medcial Center and New England Baptist Bone and Joint 
Institute, Boston, MA; 2Developmental Biology, Harvard School of Dental Medicine, Boston, MA; 3Cell 
Biology, Harvard Medical School, Boston, MA 
A20 INTEGRIN c~5/~1 MAY BE RESPONSIBLE FOR THE INDUCTION OF TYPE I AND TYPE III 
COLLAGEN DURING DEDIFFERENTIATION IN THE MONOLAYER CULTURED ADULT HUMAN 
ARTICULAR CHONDROCYTES 
N Fukui 1 , Y Ikeda 1 , T Ohnuki 1 , S Yamane 1 , R Suzuki 1 , S Yamamoto 2, Y Katsuragawa 3, LJ Sandell 4, T 
Ochi 1 
1Clinical Reserach Center, National Hospital Organization Sagamihara Hospital, Sagamihara, 
Kanagawa, Japan; 2Orthopaedic Surgery, Tokyo Metropofitan Hospital for Gerontology, Itabashi, Tokyo, 
Japan; 3Orthopaedic Surgery, National Medical Center of Japan, Shinjyuku, Tokyo, Japan; 
4Orthopaedic Surgerty, Washington University School of Medicine, St. Louis, MO 
A21 THE EFFECTS OF MECHANICAL DEFORMATION, TISSUE AGE, AND CULTURE DURATION ON 
THE TRANSCRIPTION OF CHONDROITIN SULFATE BIOSYNTHESIS ASSOCIATED ENZYMES IN 
A BOVINE CARTILAGE EXPLANTS 
JD Szafranski 1 , AH Plaas 2, AJ Grodzinsky 1 
1Biological Engineering Division, MIT, Cambridge, MA; 2Biochemistry and Molecular Biology, USE 
Tampa, FL 
Young Investigator Awardee 
A22 INTEGRIN-DEPENDENT REGULATION OF PROTEOGLYCAN SYNTHESIS IN CULTURED HUMAN 
ARTICULAR CHONDROCYTES FOLLOWING MECHANICAL STIMULATION 
M Maruo Holledge 1 , SJ Millward-Sadler 2, DM Salter 1 , G Nuki 1 
10steoarticular Research Group, Medical College, University of Edinburgh, Edinburgh, Scotland, 
2 United Kingdom; Division of Laboratory and Regenerative Medicine, University of Manchester, 
Manchester, Scotland, United Kingdom 
Concurrent Sessions 
OA Genetics 
Session Chairs: Rocky S. Tuan, Naoshi Fukui 
Novel Genetic Markers in Osteoarthritis 
John Loughlin, PhD 
A23 ABNORMAL EXPRESSION OF CARTILAGE-DEGRADING ENZYMES IN HUMAN 
OSTEOARTHRITIC CHONDROCYTES IS ASSOCIATED WITH DNA DE-METHYLATION OF 
SPECIFIC PROMOTER CpGs 
HI Roach 1 , N Yamada 2, KS Cheung 1 , S Kokubun 2, F Bronner 3 
1Bone & Joint Research Group, University of Southampton, Southampton, United Kingdom; 
2Orthopaedic Surgery, Tohoku University, Sendai, 3 Japan; Pharmacology, University of Connecticut 
Health Center, Farmington, CT 
A24 POLYMORPHISM IN THE 3' UTR OF COL9A1 IS ASSOCIATED WITH PRIMARY HIP 
OSTEOARTHRITIS 
K Chapman, B Dowling, L Southam, Z Mustafa, A Ferreira, A Carr, J Loughlin 
Institute of Muscu/oske/eta/ Sciences, Botnar Research Centre, University of Oxford, Oxford, United 
Kingdom 
A25 EVIDENCE FOR FAMILIAL AGGREGATION OF RADIOLOGICAL PROGRESSION IN FAMILIAL 
GENERALIZED OSTEOARTHRITIS. THE CARP STUDY 
SA Botha-Scheepers 1, PE Slagboom 2, I Watt 3, M-P Hellio le Graverand 4, FR Rosendaal 5, FC 
Breedveld 1 , M Kloppenburg 1 
1Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands; 2Department 
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6:15 PM-6:30 PM A26 
5:00 PM-5:30 PM 
5:30 PM-5:45 PM A27 
5:45 PM-6:00 PM A28 
6:00 PM-6:15 PM A29 
6:15 PM-6:30 PM A30 
of Molecular Epidemiology, Leiden University Medical Center, Leiden, Netherlands; 3Department of 
Radiology, Leiden University Medical Center, Leiden, Netherlands; 4Pfizer Global Research & 
Development, Ann Arbor, MI; 5Department of Clinical Epidemiology and Haematology, Leiden 
University Medical Center, Leiden, Netherlands 
THE DIFFERENTIAL ALLELIC EXPRESSION OF THE FRZB GENE IS COMMON IN ARTICULAR 
CARTILAGE AND MAY BE AN ADDITIONAL MECHANISM THROUGH WHICH FRZB INFLUENCES 
SUSCEPTIBILITY TO OSTEOARTHRITIS 
S Snellinq, A Ferreira, J Loughlin 
Institute of Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Oxford, United 
Kingdom 
Joint Imaging 
Session Chairs: Martha Gray, Felix Eckstein 
PM Imaging in Osteoarthritis 
Timothy J. Mosher, MD 
IMPROVED PRECISION IN THE QUANTIFICATION OF KNEE ALIGNMENT ANGLE 
B Goker 1 , JA Block 2 
1Medicine/Rheumatology, Gazi University Medical School, Ankara, Turkey; 2Section of Rheumatology, 
Rush University Medical Center, Chicago, IL 
REPRODUCIBILITY AND SENSITIVITY TO CHANGE OF VARIOUS METHODS OF JOINT SPACE 
WIDTH (JSW) MEASUREMENTS IN OSTEOARTHRITIS OF THE HIP (OAH). A DOUBLE READING 
OF THREE DIFFERENT RADIOGRAPHIC VIEWS TAKEN WITHIN A 3-YEAR TIME-INTERVAL 
E Maheu 1 , C Cadet 2, M Marty 3, M Dougados 4, S Ghabri 3, I Kerloch 5, B Mazi~res 6, TD Spector 7, E 
Vignon 8, MG Lequesne 9 
1Rheumatology Unit, St Antoine Hospital, Paris, France; 2None, None, Paris, France; 3Clinica and 
Statistica, Issy Les Moulineaux, France; 4 Rheumatology Institute, Cochin Hospital, Paris, France; 
5 Expanscience Labs, Courbevoie, France; 6Service Rhumatologie, Rangueil Hospital, Toulouse, 
France; 7Twin Research Unit, St Thomas's Hospital, London, United Kingdom; 8Service Rhumatologie, 
Lyon-Sud Hospital, Lyon, France; 9Service Rhumatologie, Leopold Bellan Hospita, Paris, France 
FUNCTIONAL CARTILAGE MRI: EVALUATING THE EFFECT OF AGE AND TRAINING STATUS ON 
CARTILAGE RESPONSE TO EXERCISE 
TJ Mosher, Y Liu, MB Smith 
Radiology, Penn State University College of Medicine, Hershey, PA 
QUANTITATIVE CARTILAGE IMAGING BEFORE AND AFTER GADOLINIUM APPLICATION 
F Eckstein 1,2, R Buck 3, J Kotyk 3, MP Hellio Le Graverand 3, A Remmers 3, J Evelhoch 4, M 
Hudelmaier 1,2, C Charles 5 
1Institute of Anatomy m MSR, PMU, Salzburg, Austria; 2 Chondrometrics GmbH, Ainring, Germany; 
3Global Research and Developement, Pfizer, Ann Arbor; 4AMGEN, Thousand Oaks, CA; 5DIAL, Duke 
University, Durham, NC 
Saturday,  December  10 
7:15AM-8:15AM Breakfast Session C 
Transgenic Models of Osteoarthritis 
Wim B. Van Den Berg, PhD 
Breakfast Session D 
Evaluating Pain in Osteoarthritis 
Maxime Dougados, MD 
8:30 AM - 10:00 AM Plenary Session II 
Obesity: An Overview 
Session Chairs: Leena Sharma, George Nuki 
8:30 AM-8:45 AM Obesity and Osteoarthritis: Clinical Aspects and Basic Aspects 
Michele M. Hooper, MD, MS 
8:45 AM-9:00 AM Adipocytokines and Osteoarthritis 
Pascal Pottie, PhD 
xii Sc ient i f ic  P rogram 
9:00 AM-9 :15  AM 
9:15 AM-9 :30  AM 
9:30 AM -9 :45  AM 
9:45 AM-  10:00 AM 
10:30 AM-12:15  PM 
10:30 AM-11:00  AM 
11:00 AM-12:15  PM 
11:00AM-11:15  AM 
11:15 AM-11:30AM 
11:30 AM-11:45  AM 
11:45 AM-12:00  PM 
12:00 PM-12:15  PM 
A31 ASSOCIATIONS BETWEEN BODY MASS INDEX, BODY COMPOSITION, FAT DISTRIBUTION AND 
KNEE SYMPTOMS SEVERITY IN AFRICAN-AMERICAN AND CAUCASIAN WOMEN 
LM Abbate 1'2, JB Renner 1 , TA Schwartz ~,3, CG Helmick 4, JM Jordan ~,2 
1Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC; 2Department of 
Epidemiology, University of North Carolina, Chapel Hill, NC; 3Department of Biostatistics, University of 
North Carolina, Chapel Hill, NC; 4Arthritis Program, Centers for Disease Control and Prevention, 
Atlanta, GA 
A32 INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-3: RELATION TO IGF LEVELS AND 
NUCLEAR LOCALIZATION DURING HUMAN OSTEOARTHRITIS 
EB Hunziker 1 , E Kapfinger 1 , TI Morales 2,3 
I lTI Research Institute for Dental and Skeletal Biology, University of Bern, Bern, Switzerland; 
2Orthopaedic Surgery, Massachusetts General Hospital, Boston, MA; 3Orthopaedic Surgery, Harvard 
Medical School, Cambridge, MA 
A33 PRESENCE OF OXIDIZED LOW DENSITY LIPOPROTEIN (OX-LDL) WITH LECTIN-LIKE OXIDIZED 
LOW DENSITY LIPOPROTEIN RECEPTOR-1 (LOX-1) CORRELATES TO DEGENERATION OF 
HUMAN OSTEOARTHRITIC CARTILAGE 
M Akagi, M Kanata, A Nishimura, S Mori, C Hamanishi 
Department of Orthopedic Surgery, Kinki University School of Medicine, Osaka-Sayama, Japan 
A34 PGE2 SYNTHESIS IN CARTILAGE EXPLANTS UNDER COMPRESSION: COX-2 AND mPGES-1 
ARE MECHANOSENSITIVE GENES 
F Berenbaum 1 , M Gosset 2, A Levy 2, A Pigenet 2, S Thirion 2, M Raymondjean 2, C Jacques 2 
1 Department of Rheumatology, Saint-Antoine Hospital, Paris, France; 2physiology and 
Physiopathology, UMR 7079, CNRS, Paris 6 University, Paris, France 
Plenary Session//I 
Business Meeting and Young Investigator Awards 
Session Chair: Martin Lotz 
Business Meeting 
Young Investigator Awards 
A35 IS BMI ASSOCIATED WITH THE ONSET AND PROGRESSION OF OSTEOARTHRITIS OF THE 
KNEE AND HIP? THE ROTTERDAM STUDY 
M Reiiman 1 , JN Belo 2, AM Lievense 2, JM Hazes 3, HA Pols 4, SM Bierma-Zeinstra 2 
1 Orthopaedics, Erasmus Medical Center, Rotterdam, Netherlands; 2General Practice, Erasmus 
Medical Center, Rotterdam, Netherlands; 3Rheumatology, Erasmus Medical Center, Rotterdam, 
Netherlands; 4Internal Medicine, Erasmus Medical Center, Rotterdam, Netherlands 
A36 AVAILABILITY AND CHARACTERIZATION OF HUMAN ADULT MESENCHYMAL STEM CELLS 
FOR CARTILAGE TISSUE ENGINEERING FROM YOUNG AND OLDER PATIENTS 
A Scharstuhl 1,3, B Schewe 2, K Benz 1 , WK Aicher 4, HJ BL)hring 4, C Gaissmaier 3, R Stoop 1 
1 Cell Biology, NMI Natural and Medical Sciences Institute, Reutlingen, Germany; 2Hospital for Workers 
Compensation TEtbingen, TEtbingen, Germany; 3TETEC AG, Reutlingen, Germany;4University Clinic 
of TEtbingen, TEtbingen, Germany 
A37 METABOLISM OF LUBRICIN IN ASSOCIATION WITH CARTILAGE AND SYNOVIAL JOINT 
PATHOLOGY 
ARC Jones, R Sheldon, M Majumdar, D Peluso, R Zollner, EA Morris, CR Flannery 
Womens Health & Muscoloskeletal Biology, Wyeth Research, Cambridge, MA 
A38 DOWN-REGULATION OF A CHEMOKINE RECEPTOR CXCR4 BY SMALL INTERFERING RNA 
INHIBITS MMP 13 RELEASE AND ENHANCES TIMP 1 EXPRESSION IN ARTICULAR 
CHONDROCYTES 
L Wei, X Sun, Z Wang, R Terek, Q Chen 
Orthopaedics, Brown Medical School, Providence, RI 
A39 LPS INDUCED CATABOLIC EFFECT ON ARTICULAR CARTILAGE IS DEPENDENT ON THE 
PRESENCE OF TOLL-LIKE RECEPTOR-4 AND IS ANTAGONIZED BY OSTEOGENIC PROTEIN-1 
K Bobacz, IG Sunk, L Amoyo, JS Smolen 
Department of Internal Medicine ill, Division of Rheumatology, Medical University of Vienna, Vienna, 
Austria 
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1:30 PM-3:00 PM 
3:00 PM-4 :30  PM 
3:00 PM-3:30 PM 
3:30 PM-3:45 PM A40 
3:45 PM-4:00 PM A41 
4:00 PM-4:15 PM A42 
4:15 PM-4:30 PM A43 
3:00 PM-3:30 PM 
3:30 PM-3:45 PM A44 
3:45 PM-4:00 PM A45 
4:00 PM-4:15 PM A46 
4:15 PM-4:30 PM A47 
Poster Session I1: Presenters in Attendance 
Posters P208-P366 
Concurrent Sessions 
Growth Factors and Cytokines 
Session Chairs: Steven Abramson, Gabriel Herrero-Beaumont 
Growth Factor Networks in Osteoarthritis 
Anneliese D. Recklies, PhD 
BONE MORPHOGENETIC PROTEIN AND WNT SIGNALING PATHWAYS ARE CRITICAL IN JOINT 
CARTILAGE HOMEOSTASIS IN VIVO 
RJ Lories 1 , K Reekmans 1 , J Peeters 1 , P Tylzanowski 1, I Derese 1 , T Thomas 2, FP Luyten 1 
1Laboratory for Skeletal Development and Joint Disorders, University Hospitals Leuven, Leuven, 
Belgium; 2Center for Biologics Evaluation and Research, FDA, Rockville, MD 
INTERLEUKIN (IL)-6/SOLUBLE IL-6R DOWN-REGULATION OF HUMAN TYPE II COLLAGEN 
GENE EXPRESSION IN ARTICULAR CHONDROCYTES 
B Poree, M Kypriotou, C Chadjichristos, G Beauchef, E Renard, JP Puiol, P Galera 
Laboratory of Connective Tissue Biochemistry, Faculty of Medicine, Caen, France 
A NOVEL ROLE FOR SOCS3 IN CARTILAGE DESTRUCTION VIA INDUCTION OF 
CHONDROCYTE DESENSITIZATION TOWARDS IGF-1 
FAJ van de Loo, RL Smeets, S Veenbergen, OJ Arntz, MB Bennink, LAB Joosten, WB van den Berg 
Rheumato/ogy Research and Advanced Therapeutics, Radboud University Nijmegen Medical Centre, 
Nijmegen, Netherlands 
REDUCED TGF-BETA SIGNALING IN CARTILAGE OF OLD MICE: ROLE IN IMPAIRED 
CARTILAGE REPAIR 
EN Blaney Davidson, A Scharstuhl, EL Vitters, PM van der Kraan, WB van den Berg 
Experimental Rheumatology and Advanced Therapeutics, St. Radboud University Medical Center 
Nijmegen, Nijmegen, Netherlands 
Young Investigator Awardee 
Socioeconomic Impact of OsteoarthriUs 
Session Chairs: Jeffrey N. Katz, Karel Pavelka 
Economic Impact of Osteoarthritis 
Jeffrey N. Katz, MD, MSc 
RELATIVE CONTRIBUTION OF ARTHRITIS, PAIN, QUADRICEPS STRENGTH, AND LEAN MASS 
TO PERFORMANCE-BASED FUNCTIONING 
MF Sowers 1 , ML Jannausch 1 , R Palmieri 2, CA Karvonen 1 , M Gross 2 
1 School of Pubfic Health, University of Michigan, Ann Arbor, MI; 2Division of Kinesiology, University of 
Michigan, Ann Arbor, MI 
EFFECTS OF STRENGTH TRAINING ON THE INCIDENCE AND PROGRESSION OF KNEE 
OSTEOARTHRITIS (OA) 
AE Mikesky 1 , SA Mazzuca 2, KD Brandt 2, SM Perkins 2, KA Lane 2 
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